TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Change in bladder wall thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Prevalence of upper limb venous thrombosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in Fat mtDNA Content
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in PBMC mtDNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Pain trajectories after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in heart rate variability (SDNN)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in heart rate variability (LF band power)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in heart rate variability (HF band power)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resistance of specific organism to antibiotics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change in Anthropometric Measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-Monitoring Adherence over Time
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Capacity of functional walking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak Power Output
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Death or pneumonia recurrence
Endpoint domain: Mortality/survival
Primary endpoint: Contraceptive failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient Satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Musculoskeletal functional recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: DAS28 (Disease Activity Score in 28 Joints)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of Pain in a 100mm Visual Analogue Scale (VAS 100mm)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rheumatoid Arthritis Flare Questionnaire (RA-FQ) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alpha Angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: P300 response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: 7-day cigarette smoking cessation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in tissue oxygen delivery index (tODI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: OAB-V8 questionnaire score improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of Participants Who Developed Anti-tezepelumab Antibodies After Initiation of Treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Fc-IgE Receptor density change on basophils
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Video Consultations Completed
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in Duodenal Polyp Burden
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Postoperative diabetes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Number of patients with ECG changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of patients with changes in physical examination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients with changes in BMI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of patients with changes in laboratory examination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent Change in Serum Z-Alpha-1 Antitrypsin (Z-AAT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in number of reflux episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Detection probability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional capacity measured by VO2 peak
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: change in wound surface area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: change in signs of clinical infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: change in microbial load
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Sensitivity and Specificity of FDG PET/CT and Tc99mHIDA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: size of the upper airways
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Blood pressure and heart rate maintenance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: IEF-5 Score Variation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: New York Heart Classification
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Quality of Life Improvement (KCCQ score)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Quality of Life Improvement (EQ5D)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of participants diagnosed with acute diverticulitis by Ultrasonography
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Number of participants diagnosed with acute diverticulitis by Computerized Tomography
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Pain measured on Visual Analog Scale (VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tumor volume of cutaneous neurofibromas
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Estimated absolute lymphocyte count (ALC) change from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Estimated CD4+ count change from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Estimated CD8+ count change from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Periodontal Pocket Depth Reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants with HBV DNA < 20 IU/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: serum Annexin A2 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change of running time to exhaustion under 80% of maximal heart rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of atrial fibrillation after CABG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Major cardiovascular and cerebral events (MACCE)
Endpoint domain: Mortality/survival
Primary endpoint: Time-normalized Number of HAE Attacks (Per Month)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Model for end-stage Liver Disease score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Volume of the lower limb
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neuroinflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Overall Survival (OS) in overall population
Endpoint domain: Mortality/survival
Primary endpoint: Overall Survival (OS) in PD-L1 positive population
Endpoint domain: Mortality/survival
Primary endpoint: Changes in GER pH-MII features
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Activity Scale for Kids performance version (ASKp)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Rate of Positive Serological Immune Status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Modified Rankin Scale (mRS) 0-1 (freedom from disability)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Vital signs (blood pressure, heart rate, respiratory rate)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Definite Stent Thrombosis
Endpoint domain: Adverse events/effects
Primary endpoint: Any Bleeding Event
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Unmet supportive care needs
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Change in the percentage of donor-derived cell-free DNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of cervical specimens identified as having or not having glandular and/or squamous neoplasia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Kujala Scale for Anterior Knee Pain
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Number of Participants With Freedom From Surgery for Valve Dysfunction, Death, and Moderate to Severe (3+) or Severe (4+) Mitral Regurgitation (MR)
Endpoint domain: Mortality/survival
Primary endpoint: Time to eye-opening
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Time to discharge from OR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Proportion of Participants Experiencing Regimen Limiting Toxicity (RLT)
Endpoint domain: Adverse events/effects
Primary endpoint: Mean Percentage of CD8+ T-cell Responses in Pre- and Post-vaccine PBMC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mean Percentage of CD4+ T-cell Responses in Pre- and Post-vaccine PBMC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in optical coherence tomography (OCT) central subfield (CSF) thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma concentration of LipoCol and lovastatin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Inclusion Body Myositis Functional Rating Scale (IBMFRS) Total Score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Standard Uptake Value Ratio Compared to the Cerebellum (SUVR) Area Under the Curve (AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Immune-related overall response rate (irORR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of Subjects With a Hemagglutination Inhibition (HI) Antibody Response Associated With Seroconversion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of Subjects Achieving an HI Antibody Titer >= 1:40
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of Subjects With Injection Site and Systemic Reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Identification of DNA abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Analgesic Failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global Treatment Response Success
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: RSV-specific immune responses in blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Incidence of Treatment-Emergent Serious Adverse Events (TE-SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Stool Metabolome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum CNP Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subretinal fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Participation in medical supervision program
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Estimated cost avoidance
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Pain in hip at 24 hours following surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: corneal endothelial cell count
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient's psychological adjustment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Insomnia Severity Index Score
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Proportion of subjects affected by serious adverse device effects (SADEs)
Endpoint domain: Adverse events/effects
Primary endpoint: NIH-CPSI total Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Osseous consolidation of the transplant
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Evaluation pre- and postoperative pain (VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection of axillary tumor burden
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Comparative bioavailability of naproxen
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: partial arterial pressure of end-tidal CO2 (PetCO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: partial arterial pressure of transcutaneous CO2 (PtcCO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: partial arterial pressure of carbon dioxide (PaCO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Urinary Distress Inventory, Short Form (UDI-6)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incontinence Impact Questionnaire, Short Form (IIQ-7)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Participants With Potentially Clinically Significant (PCS) Abnormal Laboratory Values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Shifts in Electrocardiogram (ECG) Findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Participants With Clinically Significant (CS) Hearing Changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Change in Intraventricular Septum Percentage of Lipid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean Change in Hepatic Percentage of Lipid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of Patients With Adverse Events (AEs), Serious Adverse Events (SAEs) and Deaths
Endpoint domain: Adverse events/effects
Primary endpoint: Mean Percent Change From Baseline in Thigh Muscle Volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Inflammatory Peritoneal Markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Remodeling Peritoneal Markers (Gene Expression (mRNA) Levels)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oxidative Stress Response Marker: MDA (Malondialdehyde)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Apoptotic Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Protocol Violation Rate
Endpoint domain: Adverse events/effects
Primary endpoint: Cessation of Blister Formation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Number of whole genome sequences for SARS-CoV-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Rate of renal SCAR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change in Anxiety Levels
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: ADHD Rating Scale-IV (ADHD-RS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neutrophil response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: 12-month Limb Salvage Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Point-prevalence of hospital-onset diarrhoea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in lumbar bone density
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number and frequency of S. pneumonia positive serotypes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Caregiver's assessment of infant pediatric GORD symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in mean hot-flashes frequency and intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Basophil Surface IgE
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Functional capacity improvement (percent change in VO2 MAX)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of exercise training
Endpoint domain: Adverse events/effects
Primary endpoint: Nasal potential difference (NPD) measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Brain activity during rest
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Brain activity during monetary wins and losses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: sepsis mortality
Endpoint domain: Mortality/survival
Primary endpoint: Vaccination completion assessment rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Coronary luminal stenosis severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Maximum observed plasma naloxone concentration (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the naloxone concentration versus time curve (AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Site-level Rates of Weight Monitoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reductions in Externalizing Scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from baseline in pain score at week 14
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Differentiation of Mild Cognitive Impairment (MCI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Detection of IDH2 mutations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: composite end point
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Exponential Rate of Change in Serum Potassium Levels During the Initial 48 Hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Exponential Rate of Change in Serum Potassium Levels in the Subacute Phase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in cerebral glucose metabolic rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: compliance of menu and meal with Child and Adult Care Food Program requirements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: dietary quality of foods served
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diabetes management
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Development of moderate or severe OHSS necessitating admission
Endpoint domain: Adverse events/effects
Primary endpoint: Penetration of BI
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of patients with histologically demonstrated adenoma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Objective quality of the health recommender system
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Subjective quality of the health recommender system
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Engagement at aggregated level - Mobile application usage frequency
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of patients with full stomach
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in Global Longitudinal Strain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: histologic clearance of basal cell carcinoma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Resilience scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing